Publication:
Rewiring enzyme regulation: Allosteric drugs and predictive tools

dc.contributor.coauthorFidan, Vahap Gazi (59717529100)
dc.contributor.coauthorIlim, Konuralp (60110453200)
dc.contributor.coauthorGürsoy, Attila (8630095700)
dc.contributor.coauthorOzkan, S. Banu (57218540137)
dc.contributor.coauthorKeskin, Özlem (7004124142)
dc.date.accessioned2025-12-31T08:24:00Z
dc.date.available2025-12-31
dc.date.issued2025
dc.description.abstractAllosteric modulation offers an increasingly attractive route for precise intervention in enzymatic pathways. This review outlines emerging strategies for the identification and exploitation of allosteric sites, emphasizing computational frameworks that integrate evolutionary, structural, and dynamic features with machine learning models. We discuss how perturbation-based simulations, network analyses, and deep mutational data are reshaping our understanding of allosteric regulation. In parallel, advances in experimental techniques have enabled validation of cryptic and functionally relevant pockets across diverse enzyme families. We further catalog FDA-approved allosteric modulators of enzymes, highlighting therapeutic designs that leverage distal regulation to enhance specificity and overcome resistance. Taken together, these developments reveal the growing utility of allostery in drug design and underscore its potential to expand the therapeutic target space beyond conventional binding sites. © 2025 Elsevier B.V., All rights reserved.
dc.description.fulltextYes
dc.description.harvestedfromManual
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.identifier.doi10.1016/j.sbi.2025.103159
dc.identifier.eissn1879-033X
dc.identifier.embargoNo
dc.identifier.issn0959-440X
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-105016783252
dc.identifier.urihttps://doi.org/10.1016/j.sbi.2025.103159
dc.identifier.urihttps://hdl.handle.net/20.500.14288/31764
dc.identifier.volume95
dc.keywordsAllosteric Site
dc.keywordsAllosterism
dc.keywordsBinding Site
dc.keywordsDrug Design
dc.keywordsDrug Development
dc.keywordsEnzyme Regulation
dc.keywordsFood And Drug Administration
dc.keywordsHuman
dc.keywordsMachine Learning
dc.keywordsNetwork Analysis
dc.keywordsReview
dc.keywordsSimulation
dc.language.isoeng
dc.publisherElsevier Ltd
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofCurrent Opinion in Structural Biology
dc.relation.openaccessYes
dc.rightsCC BY-NC-ND (Attribution-NonCommercial-NoDerivs)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleRewiring enzyme regulation: Allosteric drugs and predictive tools
dc.typeReview
dspace.entity.typePublication

Files